Payment overview · 2025
General Payments
$25.34
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Yudez, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · LAS VEGAS, NV · NPI 1376723056
Verified facts
What the public records show
CMS Open Payments records show Michael Yudez, D.O. received $25.34 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $25.34 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.34 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $25.34 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 556 | 173 |
| Alprazolam | Alprazolam | 554 | 94 |
| Levothyroxine Sodium | Levothyroxine Sodium | 413 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 366 | 111 |
| Losartan Potassium | Losartan Potassium | 290 | 92 |
| Lisinopril | Lisinopril | 272 | 81 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 265 | 85 |
| Pantoprazole Sodium | Pantoprazole Sodium | 242 | 70 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 216 | 129 |
| Metoprolol Succinate | Metoprolol Succinate | 208 | 69 |
| Omeprazole | Omeprazole | 208 | 77 |
| Zolpidem Tartrate | Zolpidem Tartrate | 204 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 195 | 68 |
| Simvastatin | Simvastatin | 190 | 50 |
| Allopurinol | Allopurinol | 179 | 49 |
| Metformin Hcl | Metformin Hcl | 168 | 62 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 162 | 41 |
| Gabapentin | Gabapentin | 131 | 43 |
| Diazepam | Diazepam | 128 | 24 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 126 | 35 |
| Trazodone Hcl | Trazodone Hcl | 119 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 118 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 30 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 115 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 109 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 107 | 35 |
| Mounjaro | Tirzepatide | 105 | 18 |
| Ibuprofen | Ibuprofen | 96 | 26 |
| Meloxicam | Meloxicam | 95 | 32 |
| Oxycodone Hcl | Oxycodone Hcl | 94 | 16 |
| Atenolol | Atenolol | 93 | 25 |
| Pioglitazone Hcl | Pioglitazone Hcl | 89 | 27 |
| Potassium Chloride | Potassium Chloride | 84 | 30 |
| Carvedilol | Carvedilol | 81 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 77 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 75 | 22 |
| Furosemide | Furosemide | 74 | 28 |
| Azithromycin | Azithromycin | 72 | 47 |
| Famotidine | Famotidine | 71 | 19 |
| Metformin Hcl Er | Metformin Hcl | 71 | 26 |
| Donepezil Hcl | Donepezil Hcl | 68 | 23 |
| Montelukast Sodium | Montelukast Sodium | 68 | 20 |
| Rybelsus | Semaglutide | 67 | 22 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 65 | 19 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 65 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 16 |
| Temazepam | Temazepam | 63 | suppressed |
| Clonazepam | Clonazepam | 62 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | 17 |
| Fenofibrate | Fenofibrate | 62 | 21 |
| Sertraline Hcl | Sertraline Hcl | 61 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 60 | 15 |
| Alendronate Sodium | Alendronate Sodium | 59 | 16 |
| Pregabalin | Pregabalin | 59 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 58 | 19 |
| Finasteride | Finasteride | 57 | 16 |
| Tramadol Hcl | Tramadol Hcl | 57 | 19 |
| Xarelto | Rivaroxaban | 57 | 15 |
| Eliquis | Apixaban | 56 | 19 |
| Glimepiride | Glimepiride | 55 | 18 |
| Clonidine Hcl | Clonidine Hcl | 54 | 16 |
| Testosterone Cypionate | Testosterone Cypionate | 51 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 19 |
| Ezetimibe | Ezetimibe | 46 | 13 |
| Glipizide | Glipizide | 46 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | 17 |
| Prednisone | Prednisone | 42 | 14 |
| Synthroid | Levothyroxine Sodium | 42 | suppressed |
| Ramipril | Ramipril | 41 | 11 |
| Valacyclovir | Valacyclovir Hcl | 41 | 13 |
| Jardiance | Empagliflozin | 40 | 13 |
| Propranolol Hcl | Propranolol Hcl | 39 | 16 |
| Sumatriptan Succinate | Sumatriptan Succinate | 39 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | 14 |
| Topiramate | Topiramate | 37 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 36 | suppressed |
| Ozempic | Semaglutide | 36 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 35 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 34 | 24 |
| Estradiol | Estradiol | 34 | 13 |
| Meclizine Hcl | Meclizine Hcl | 34 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 33 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 32 | 11 |
| Torsemide | Torsemide | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 31 | suppressed |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | 12 |
| Celecoxib | Celecoxib | 28 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 28 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 28 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 26 | suppressed |
| Ketoconazole | Ketoconazole | 26 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 26 | 17 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 25 | 15 |
| Trulicity | Dulaglutide | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 11 |
| Carisoprodol | Carisoprodol | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | 11 |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Lovastatin | Lovastatin | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Ibu | Ibuprofen | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Glipizide Er | Glipizide | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Pentoxifylline | Pentoxifylline | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Risperidone | Risperidone | 17 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Eszopiclone | Eszopiclone | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Qulipta | Atogepant | 15 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Nadolol | Nadolol | 14 | suppressed |
| Ofloxacin | Ofloxacin | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | 11 |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Oxazepam | Oxazepam | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Spironolactone | Spironolactone | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Kerendia | Finerenone | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.34 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error